This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ResMed’s 8K filing here.
About ResMed
ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
Featured Articles
- Five stocks we like better than ResMed
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Invest in Small Cap Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 10/21- 10/25
